UTI AMC Q4 FY26 loss: stock drops 5% on MTM hit

What triggered the fall in UTI AMC shares

UTI Asset Management Company (UTI AMC) came under pressure in early trade after reporting a loss for the March 2026 quarter (Q4 FY26). The stock fell 5.21% to ₹982 following the result. On the NSE, it opened flat at ₹1,037.50 and then slipped to an intraday low of ₹980.85. Around 9:30 AM, the stock was quoted near ₹982.85, down about 5%.

The sharp move followed weak headline earnings, even as revenue from operations showed a modest year-on-year rise. Multiple reports in the provided data cite different loss numbers for Q4 FY26, but both point to a swing from profit to loss versus the same quarter last year.

Q4 FY26 headline numbers: profit turns into loss

One set of figures says UTI AMC reported a consolidated net loss of ₹67 crore in Q4 FY26, versus a net profit of ₹87 crore in Q4 FY25. The same report said total revenue from operations rose 4% year-on-year to ₹390 crore in the March 2026 quarter. It also said total expenses jumped 89% year-on-year to ₹419 crore.

A separate market update cited a net loss of ₹51.4 crore in Q4 FY26, compared with a net profit of ₹102 crore in Q4 FY25. That update attributed the impact to mark-to-market (MTM) losses, noting negative other income of ₹163 crore.

Taken together, the common thread across the sources is that operating revenue did not collapse, but treasury and valuation-linked lines moved sharply, pulling the bottom line into the red.

Fair value and other income hit earnings

The company recorded a net loss on fair value changes of ₹176 crore in Q4 FY26, compared with ₹10 crore in the same period last year, according to the results summary provided. This kind of swing typically reflects valuation changes on the investment book.

The other update pointed to MTM losses as the key reason, with negative other income of ₹163 crore. While the two numbers are not described identically, both point to a large adverse move in non-operating or valuation-related income in the quarter.

Pre-tax performance also weakened sharply

UTI AMC recorded a pre-tax loss of ₹16.80 crore in Q4 FY26, compared with a pre-tax profit of ₹154 crore in Q4 FY25, according to the same results note. That gap is consistent with the sharp rise in expenses and losses from fair value changes described in the quarter.

The results commentary cited by JM Financial said the performance was “fine at operating level”, but higher-than-expected fall in other income dragged earnings. JM Financial also said FY26 remained a weak year for the company, impacted by volatile markets and one-off costs related to VRS and the labour code.

AUM snapshot: scale remains large

Despite the earnings pressure, the company continues to manage sizeable assets. Total group assets under management (AUM) for UTI AMC stood at ₹23,42,038 crore at the end of March 2026.

The broader context in the provided material also includes UTI AMC’s disclosure from an earlier quarter. In Q2 FY26, total group AUM stood at ₹22,41,837 crore, while UTI MF’s quarterly average assets under management (QAAUM) was ₹3,78,413 crore as of September 30, 2025. SIP AUM as of quarter end stood at ₹42,267 crore.

What brokerages had expected before the results

Ahead of the Q4 results, an outlook note dated April 20, 2026 said UTI AMC’s net profit for the quarter ended March was expected to decline due to a fall in market share and low treasury income. The average estimate from eight brokerages was net profit of ₹99.16 crore (INR 991.63 million), down 20% year-on-year, with the lowest estimate at ₹49 crore (INR 490 million) and the highest at ₹130 crore (INR 1.30 billion).

The same note said average estimated net sales were ₹376.53 crore (INR 3.765 billion), up nearly 19% year-on-year but down 11% sequentially. The market context cited included a near 15% fall in the Nifty 50 during the March quarter and a 45 basis point rise in the 10-year benchmark government bond yield.

Mutual fund flow backdrop and market share concerns

The outlook note also referenced AMFI data showing the mutual fund industry saw a net outflow of ₹2,40,000 crore (INR 2.40 trillion) in March, after net inflows of ₹1,56,000 crore (INR 1.56 trillion) and ₹94,530 crore (INR 945.30 billion) in January and February, respectively.

Brokerages tracking UTI AMC said it likely lost market share, especially in equity funds, due to low net inflows. Motilal Oswal was quoted as expecting March-quarter QAAUM to “remain flat, with declines in equity and debt AUM (to be) offset by growth in passives (funds).”

Key figures at a glance

Ratings, targets, and how the Street is split

Motilal Oswal Financial Services reiterated a ‘Buy’ rating on UTI AMC with a target of ₹1,270, implying an upside of around 29% from the CMP cited in the report. Separately, the pre-result outlook note said that, of eight brokerage reports available with Informist, seven had a ‘buy’ recommendation with an average target price of ₹1,271.43, and one had a ‘hold’ recommendation.

But the tone was not uniformly positive. JM Financial Institutional Securities was cited as calling UTI AMC the “top stock to avoid” in the asset and wealth management segment.

Market impact and what investors are reacting to

The immediate market reaction appears tied to the scale of the valuation and other-income hit, and the sharp rise in expenses, rather than a collapse in operating revenue. The quarter also landed amid volatility across equities and bonds, a combination that can impact both market levels and treasury income.

For investors, the key monitoring variables from the data provided are the stability of operating revenue, the trajectory of cost items including one-off costs such as VRS and labour-code related expenses, and how sensitive reported earnings remain to MTM and fair-value movements.

Conclusion

UTI AMC’s Q4 FY26 result triggered a swift sell-off, with the stock falling over 5% as the company reported a quarterly loss and large negative moves in fair value and other income lines. The next set of disclosures and management commentary will be watched for clarity on the drivers of MTM swings, expense run-rate, and AUM trends after the March 2026 quarter.